Relugolix-estradiol-norethisterone (also known as relugolix combination therapy or Ryeqo), is the “first of its kind” daily ...

Endometriosis UK believes that women and those assigned female at birth in the UK should be able to choose the right ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

An experimental hormone-free male contraceptive pill, developed by YourChoice Therapeutics, is showing promise in early human trials. The pill, which interferes with vitamin A signaling necessary for ...

While, on average, it takes eight years to be diagnosed with endometriosis, there are, thankfully, new breakthroughs in ...

A daily pill has been approved by NICE for treating some women with endometriosis after initially being rejected.

A new combination pill, relugolix–estradiol–norethisterone, has been approved for treating endometriosis on the NHS. This ...

The first daily pill for long-term treatment of endometriosis has been approved for use across England by the National Health ...

The treatment, called relugolix–estradiol–norethisterone (also known as relugolix combination therapy or Ryeqo), works by blocking specific hormones that contribute to endometriosis, while also ...

The NHS has approved a groundbreaking daily pill for endometriosis, offering women a faster, more convenient treatment at ...

Ryeqo is likely to start being prescribed to patients in Wales within two months, but there will be restrictions on who can ...